The Quest for Biomarkers: How Multi-Omics Could Revolutionise Fibromyalgia Diagnosis
“From a clinical perspective, recent studies have explored under-recognised aspects of FM, such as sexual & cognitive dysfunction, the role of gender, environmental exposures, & the disease’s impact on relationships & family life”
Here at the London Fibro Clinic, our Fibromyalgia Pain Doctors have been inspired by recent 2024–2025 findings. These imply that changes in an individual’s:
- Metabolism
- Inflammation
- Gut microbiota, or
- Brain structure, could serve as potential diagnostic and therapeutic targets for Pain Specialists, and the make-up of our patients’ Holistic Personalised Treatment Plans. – The latter of which incorporate conventional treatment as well as the latest state-of-the-art leading-edge therapies, and injectables (including pain blockers and Botox).
Facing Fibromyalgia (FM) With Optimism
This disorder can be described as a long-term syndrome which involves “widespread pain, high prevalence, and a significant impact on quality of life” [1]. Yet regardless of the huge amount of research that has already been undertaken, appropriate treatments and pathogenesis (the process by which a disease develops in relation to various body mechanisms), are still only partly understood, thus propelling the need for further investigation [1]. On top of this dilemma, is the fact that here in the UK, unlike Pain Doctors and Fibro Pain Doctors, the majority of GPs have not undergone the necessary extra years of training and in-house clinical expertise warranted to be able to provide sufferers with an accurate diagnose and research-backed cutting-edge innovative treatments. And even more concerning, are the reports that a percentage of women have been turned away by their GPs who have concluded that their pain, lethergy, and other fibro-associated symptoms, are ‘all in their head.’
Hope For The Future
The future for fibro suffers could be bright, and here at the London Fibro Pain Clinic, our Fibro Consultants are optimistic in terms of:
- Innovative research
- Different approaches
- New frontiers in treatment, and
- Patient care
To that end: “therapeutically, non-pharmacological strategies, particularly physical activity and psychosocial interventions, remain fundamental” [1]. Moreover, emerging fields are the future, and these include:
- Non-invasive neuromodulation
- Psychedelic therapies, and
- The integration of technologies (for example: AI and virtual reality). Areas in which our Fibro Pain Doctors are looking forward to be part of
Naturally, all our Pain Consultants here at the London Fibro Clinic are mindful that: research indicates that such advances “underscore the multifactorial nature of FM and the need for personalised, interdisciplinary approaches” [1]. – A direction that has always been our ethos.
Putting a Spotlight on Further Investigation into Fibromyalgia (FM)
Did you know that: “dysregulation of the HPA (hypothalamic-pituitary-adrenal) axis and sympathetic nervous system has been linked to chronic stress responses and neuro-inflammation, with neuroimaging and preclinical studies confirming altered pain and stress processing” [1]. Furthermore, metabolic disturbances and low-grade inflammation such as increased adipose tissue infiltration and cytokine imbalance, exacerbate fibromyalgia symptoms even more.
Many patients are surprised when their Fibro Consultant explains to them that gut microbiota play a role in emotional and immune dysregulation. Moreover, studies from MRIs “continue to reveal brain changes that differentiate FM from other chronic pain disorders. And multi-omics approaches, including transcriptomic and metabolomic analyses, show promise as diagnostic biomarkers” [1].
Getting Things Sorted
Our Fibromyalgia Doctors are available for consultation both in-person and online.
Reference
[1]. Iannuccelli C, Favretti M, Dolcini G, Di Carlo M, Pellegrino G, Bazzichi L, Atzeni F, Lucini D, Varassi G, Leoni MLG, Fornasari DMM, Conti F, Salaffi F, Sarzi-Puttini P, Di Franco M. Fibromyalgia: one year in review 2025. Clin Exp Rheumatol. 2025 Jun;43(6):957-969. As cited by the U.S. National Library of Medicine.
https://pubmed.ncbi.nlm.nih.gov/40470564/
